BIO-TECHNE Corp
TECH- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000842023
No open-market purchases or sales by BIO-TECHNE Corp insiders were filed in the last 90 days; 597 institutions reported holding it in 13F filings for Q2 2026, worth $12.3B in total; 3 superinvestors hold it, including Maverick Capital and Weitz Investment Management.
Q3 2021 vs. Q2 2021
How the institutions holding BIO-TECHNE Corp changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 512 | 6 | 567 | +61 |
| Shares | 36.6M | 20.6K | 36.8M | +187.2K (+0.5%) |
| Value | $16.5B | $9.29M | $17.8B | +$1.34B (+8.2%) |
6 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (94)
Institutions that held BIO-TECHNE Corp at the end of Q3 2021 but not at the end of Q2 2021.
Sold out (33)
Institutions that held BIO-TECHNE Corp at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (6)
Institutions that held BIO-TECHNE Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 14,954 | $6.73M |
| Kensington Investment Counsel, LLC | 4,199 | $1.89M |
| Financial Consulate Inc. | 841 | $379.0K |
| QS Investors, LLC | 631 | $285.0K |
| CWM, LLC | 9 | $4.00K |
| First Horizon Corp | 8 | $3.00K |